About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Islet cells
- Company
- Chuck Rickert, MD, PhD
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 53 recruiting
Efficacy results: Not yet reported
53 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 26, 2026
Find a Clinical Trial Near Me
See recruiting studies for Islet cells and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT00912717
Pancreatic Adenocarcinoma Gene Environment Risk Study
University of Pittsburgh 10000 participants Est. completion 2027-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT02598349
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Not yet reported Proton Collaborative Group 60 participants Est. completion 2040-10 4 sitesOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT03492671
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
Not yet reported Loma Linda University 30 participants Est. completion 2026-09 1 siteOther conditions: Pancreas Adenocarcinoma, Resectable Pancreatic CancerView official trial listing → -
Recruiting NCT NCT03608631
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Not yet reported, Not yet reported M.D. Anderson Cancer Center 28 participants Est. completion 2027-04-30 1 siteOther conditions: KRAS NP_004976.2:p.G12D, Metastatic Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT03785743
Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma
Not yet reported Tongji Hospital 200 participants Est. completion 2027-05-01 1 siteOther conditions: Pancreatic Carcinoma, Laparoscopic, PancreaticoduodenectomyView official trial listing → -
Recruiting NCT NCT04005690
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Not yet reported OHSU Knight Cancer Institute 90 participants Est. completion 2028-02-01 1 siteOther conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT04095195
Registry of Subjects at Risk of Pancreatic Cancer
Associazione Italiana per lo Studio del Pancreas 1000 participants Est. completion 2045-09-20 4 sitesOther conditions: Familial Pancreatic Cancer, BRCA1 Mutation, BRCA2 Mutation, Lynch Syndrome, FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome, Hereditary Pancreatitis, Peutz-Jeghers SyndromeView official trial listing → -
Recruiting NCT NCT04172532
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2027-08-01 44 sitesOther conditions: Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT04421820
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Not yet reported, Not yet reported Bold Therapeutics, Inc. 220 participants Est. completion 2026-09-01 24 sitesOther conditions: Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, CholangiocarcinomaView official trial listing → -
Recruiting NCT NCT04789486
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
Not yet reported, Not yet reported Dana-Farber Cancer Institute 100 participants Est. completion 2030-04-10 2 sitesOther conditions: Non-small Cell Lung Cancer, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer, Ductal Adenocarcinoma of the PancreasView official trial listing → -
Recruiting NCT NCT04890613
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Not yet reported Senhwa Biosciences, Inc. 52 participants Est. completion 2027-03 8 sitesOther conditions: Advanced Solid TumorView official trial listing → -
Recruiting NCT NCT04969731
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Not yet reported GC Cell Corporation 408 participants Est. completion 2027-06 1 siteOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT05172310
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Not yet reported Karolinska University Hospital 410 participants Est. completion 2029-03-31 1 site Stand-aloneOther conditions: Pancreatic Neoplasms, Stomach Neoplasms, Bile Duct Neoplasms, Epithelial Ovarian CancerView official trial listing → -
Recruiting NCT NCT05241249
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
Not yet reported Susan E. Bates 37 participants Est. completion 2026-01 1 siteOther conditions: Pancreas CancerView official trial listing → -
Recruiting NCT NCT05376592
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Wake Forest University Health Sciences 100 participants Est. completion 2031-01 2 sitesOther conditions: Pancreas Adenocarcinoma, CachexiaView official trial listing → -
Recruiting NCT NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Not yet reported, Not yet reported Revolution Medicines, Inc. 754 participants Est. completion 2027-07-26 21 sitesOther conditions: Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT05428358
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
Not yet reported University of Aarhus 200 participants Est. completion 2028-12-01 3 sitesOther conditions: Pancreatic Cancer, Pancreatic Neoplasm, Liver MetastasesView official trial listing → -
Recruiting NCT NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
AstraZeneca 24000 participants Est. completion 2026-10-01 8 sitesOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT05833217
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
Not yet reported Stanford University 55 participants Est. completion 2025-12-31 2 sites Stand-aloneOther conditions: Long COVID, Insulin Resistance, Insulin SensitivityView official trial listing → -
Recruiting NCT NCT05843877
Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
Not yet reported Technische Universität Dresden 32 participants Est. completion 2028-01 1 site Stand-aloneOther conditions: Periampullary Cancer, Postoperative Pancreatic FistulaView official trial listing → -
Recruiting NCT NCT05851534
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
Not yet reported Maastricht University Medical Center 2575 participants Est. completion 2028-09-02 13 sitesOther conditions: Prehabilitation, Pancreas Cancer, Surgery, Postoperative ComplicationsView official trial listing → -
Recruiting NCT NCT05914987
Determining Individualized Cancer Therapy in Pancreatic Cancer
Medical College of Wisconsin 1000 participants Est. completion 2033-08-01 1 siteOther conditions: Pancreatic NeoplasmsView official trial listing → -
Recruiting NCT NCT05916261
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Not yet reported Ruijin Hospital 54 participants Est. completion 2026-12-30 1 siteOther conditions: Advanced Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06043921
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
Invitae Corporation 150 participants Est. completion 2026-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06048484
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Not yet reported Gulam Manji 60 participants Est. completion 2027-04 5 sitesOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT06058442
The Pancreatic Enzymes After Gastrectomy Trial
Not yet reported University of Leipzig 188 participants Est. completion 2028-02 12 sitesOther conditions: GastrectomyView official trial listing → -
Recruiting NCT NCT06068023
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
Fondazione Poliambulanza Istituto Ospedaliero 400 participants Est. completion 2029-07-01 1 siteOther conditions: Ampullary AdenocarcinomaView official trial listing → -
Recruiting NCT NCT06163482
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
University of Cincinnati 61 participants Est. completion 2026-11-01 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Recruiting NCT NCT06252545
Promoting CT Engagement for Pancreatic Cancer With App
Not yet reported UNC Lineberger Comprehensive Cancer Center 26 participants Est. completion 2027-02-01 2 sitesOther conditions: Pancreas CancerView official trial listing → -
Recruiting NCT NCT06275737
POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric
Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 72 participants Est. completion 2028-06 11 sitesOther conditions: Pancreatic Ductal Adenocarcinoma, Esophageal CancerView official trial listing → -
Recruiting NCT NCT06386224
Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
Not yet reported Seattle Children's Hospital 280 participants Est. completion 2028-07-01 1 siteOther conditions: Pancreatitis, Chronic Pancreatitis, Acute Recurrent PancreatitisView official trial listing → -
Recruiting NCT NCT06391892
Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
Not yet reported Elisabethinen Hospital 100 participants Est. completion 2026-12-31 1 siteOther conditions: Pancreatic Cancer, Circulating Tumor Cell, Predictive Cancer ModelView official trial listing → -
Recruiting NCT NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Not yet reported Eli Lilly and Company 575 participants Est. completion 2029-06 24 sitesOther conditions: Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms, Pancreatic Neoplasm, Colorectal NeoplasmsView official trial listing → -
Recruiting NCT NCT06423326
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
Not yet reported Emory University 36 participants Est. completion 2027-12-31 1 siteOther conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT06427239
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
Not yet reported, Not yet reported Fudan University 130 participants Est. completion 2028-03 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06445062
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Not yet reported, Not yet reported Revolution Medicines, Inc. 1130 participants Est. completion 2030-03-30 32 sitesOther conditions: Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC, Gastrointestinal Cancer, Metastatic Pancreatic Ductal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT06494514
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer
Not yet reported Du Juan 40 participants Est. completion 2027-04-01 2 sitesOther conditions: Locally Advanced Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06496373
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
Not yet reported Ruijin Hospital 20 participants Est. completion 2027-06-30 1 siteOther conditions: Pancreatic Cancer Resectable, Chemotherapy-intolerantView official trial listing → -
Recruiting NCT NCT06598033
Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
Not yet reported, Not yet reported Fudan University 50 participants Est. completion 2027-10-01 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06605404
Pan-tumor MRD Study
Paradigm Health 1350 participants Est. completion 2032-04 47 sitesOther conditions: Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, Melanoma (Skin Cancer), NSCLC (Non-small Cell Lung Cancer), Pancreatic (Exocrine Only), Mix of Solid Tumors (MOST)View official trial listing → -
Recruiting NCT NCT06662006
Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56 participants Est. completion 2027-12 1 siteOther conditions: Advanced Metastatic Pancreatic CancerView official trial listing → -
Recruiting NCT NCT06663072
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Not yet reported University of Chicago 25 participants Est. completion 2026-11 1 siteOther conditions: Metastatic Pancreatic Neuroendocrine TumorView official trial listing → -
Recruiting NCT NCT06706700
Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas
IRCCS San Raffaele 586 participants Est. completion 2025-03-31 1 siteOther conditions: Intraductal Papillary Mucinous Neoplasm of Pancreas, Pancreatic CystView official trial listing → -
Recruiting NCT NCT06760364
A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
Not yet reported Tianjin Medical University Cancer Institute and Hospital 21 participants Est. completion 2039-12-24 1 siteOther conditions: Advanced Pancreatic CancersView official trial listing → -
Recruiting NCT NCT06881992
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Not yet reported Rezolute 16 participants Est. completion 2027-09 13 sitesOther conditions: Tumor Hyperinsulinism (Tumor HI)View official trial listing → -
Recruiting NCT NCT07049055
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
Not yet reported, Not yet reported Engeneic Pty Limited 144 participants Est. completion 2028-09 4 sitesOther conditions: Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT07110064
QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer
Not yet reported Du Juan 80 participants Est. completion 2028-08-31 1 siteOther conditions: Advance Pancreatic CancerView official trial listing → -
Recruiting NCT NCT07224750
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
City of Hope Medical Center 1000 participants Est. completion 2028-06-18 1 siteOther conditions: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer (GC), Colorectal Cancer ScreeningView official trial listing → -
Recruiting NCT NCT07342231
FAPi PET in Pancreatic Ductal Adenocarcinoma
Tata Memorial Hospital 60 participants Est. completion 2027-01-01 1 siteOther conditions: Pancreatic Cancer, Adenocarcinoma PancreasView official trial listing → -
Recruiting NCT NCT07450547
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Not yet reported Anagram Therapeutics, Inc. 113 participants Est. completion 2027-07 27 sitesOther conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)View official trial listing → -
Recruiting NCT NCT07478523
FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
Not yet reported University Hospital, Bordeaux 120 participants Est. completion 2029-03-21 1 siteOther conditions: Cholangiocarcinoma, Pancreatic AdenocarcinomaView official trial listing → -
Recruiting NCT NCT07619313
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Not yet reported Jonsson Comprehensive Cancer Center 46 participants Est. completion 2028-06-01 1 siteOther conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Cholangiocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8View official trial listing → -
Recruiting NCT NCT07670312
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Not yet reported, Not yet reported XYone Therapeutics, Inc 190 participants Est. completion 2030-09-15 5 sitesOther conditions: MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer, GEJ Adenocarcinoma, Colorectal Cancer, Pancreatic Adenocarcinoma, Gastric CancerView official trial listing → -
Completed NCT NCT00002955
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
Not yet reported University of Southern California 21 participants Est. completion 2006-06 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00005053
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 35 participants 15 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00006368
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Not yet reported Novartis Pharmaceuticals 60 participants Est. completion 2003-11 1 siteOther conditions: Brain and Central Nervous System Tumors, Breast Cancer, Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer, Lymphoma, Melanoma (Skin), Neoplastic SyndromeView official trial listing → -
Terminated NCT NCT00014651
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
Not yet reported Mayo Clinic Est. completion 2002-04 18 sitesOther conditions: Pancreatic Cancer, Perioperative/Postoperative ComplicationsView official trial listing → -
Completed NCT NCT00032175
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Not yet reported Cancer Research UK 508 participants Est. completion 2007-05 30 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00041639
Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer
Not yet reported, Not yet reported Gilead Sciences 75 participants Est. completion 2003-12 10 sitesOther conditions: Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT00047307
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Not yet reported National Cancer Institute (NCI) 46 participants 1 siteOther conditions: Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic CancerView official trial listing → -
Completed NCT NCT00052689
Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
Not yet reported National Cancer Institute (NCI) 88 participants 1 siteOther conditions: Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic CancerView official trial listing → -
Completed NCT NCT00057876
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
Not yet reported Eastern Cooperative Oncology Group 74 participants Est. completion 2009-05 229 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00073281
Islet Transplantation for Patients With Type 1 Diabetes
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10 participants Est. completion 2004-12 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00097071
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
Not yet reported Novo Nordisk A/S 299 participants Est. completion 2006-05 52 sitesOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT00108875
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
Not yet reported, Not yet reported Julius-Maximilians University 70 participants 1 siteOther conditions: Malignant Melanoma, Pancreatic Cancer, Colon Cancer, Cervical CancerView official trial listing → -
Completed NCT NCT00120939
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Not yet reported Pharmacyclics LLC. 25 participants 1 siteOther conditions: Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Lung Neoplasms, Gastrointestinal NeoplasmsView official trial listing → -
Completed NCT NCT00128622
Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
Not yet reported H. Kim Lyerly 24 participants Est. completion 2009-05 2 sitesOther conditions: Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00135057
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
Not yet reported Sanofi 281 participants Est. completion 2005-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00147745
Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes
Not yet reported Daiichi Sankyo 36 participants Est. completion 2008-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00174668
Insulin Glulisine in Diabetes Mellitus, Type 2
Not yet reported Sanofi 311 participants 15 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT00178763
Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Not yet reported The University of Texas Health Science Center, Houston 36 participants Est. completion 2013-06 1 siteOther conditions: Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT00191178
Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
Not yet reported Eli Lilly and Company 60 participants Est. completion 2005-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00201838
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
Not yet reported, Not yet reported Ohio State University Comprehensive Cancer Center 38 participants Est. completion 2007-05 1 siteOther conditions: Pancreatic Neoplasms, AdenocarcinomaView official trial listing → -
Withdrawn NCT NCT00228904
Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes
Not yet reported, Not yet reported Florida Atlantic University Est. completion 2011-10 1 siteOther conditions: Diabetic NeuropathyView official trial listing → -
Withdrawn NCT NCT00231192
Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
Not yet reported Children's Hospital of Philadelphia Est. completion 2007-08 1 siteOther conditions: DiabetesView official trial listing → -
Terminated NCT NCT00267683
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 9 participants Est. completion 2006-04Type 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00300950
Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer
Not yet reported GlobeImmune 176 participants Est. completion 2015-02 28 sitesOther conditions: Pancreas CancerView official trial listing → -
Terminated NCT NCT00303134
Islet Cell Transplants for Diabetes
Not yet reported Weill Medical College of Cornell University 3 participants Est. completion 2010-06-24 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00335465
Lantus Effect on Myocardial Glucose Metabolism in T2
Not yet reported Sanofi 15 participants Est. completion 2008-06 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT00336700
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Not yet reported Herbert J. Zeh, III MD, FACS 25 participants Est. completion 2011-11 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00340613
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
Not yet reported Baylor College of Medicine 36 participants Est. completion 2007-06 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00348972
Lantus in Prediabetes
Not yet reported Sanofi 20 participants 1 siteOther conditions: Hyperglycemia, Diabetes MellitusView official trial listing → -
Completed NCT NCT00360698
Insulin Glulisine in Type 2 Diabetic Patients
Not yet reported Sanofi 106 participants Est. completion 2008-08 3 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00362778
Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia
Not yet reported Hospital Clinic of Barcelona 28 participants Est. completion 2007-06Cardiovascular disease Other conditions: Diabetes, HyperglycemiaView official trial listing → -
Terminated NCT NCT00364364
Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2 participants Est. completion 2008-08 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00374283
Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients
University of Cincinnati 40 participants Est. completion 2007-10 2 sitesOther conditions: PolyomavirusView official trial listing → -
Completed NCT NCT00384215
Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
Not yet reported Sanofi 352 participants Est. completion 2005-02 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT00386399
Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2008-02 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00397787
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine
Not yet reported National Cancer Institute (NCI) 64 participants 2 sitesOther conditions: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic CancerView official trial listing → -
Completed NCT NCT00412126
Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
Not yet reported Hamilton Health Sciences Corporation 240 participants Est. completion 2005-09 1 siteOther conditions: Diabetes Mellitus, Coronary RestenosisView official trial listing → -
Completed NCT NCT00416767
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Not yet reported Federation Francophone de Cancerologie Digestive 20 participants Est. completion 2007-07Other conditions: Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic SyndromeView official trial listing → -
Completed NCT NCT00442767
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
Not yet reported Montefiore Medical Center 8 participants Est. completion 2009-02 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00443599
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
Not yet reported Boston Children's Hospital 989 participants Est. completion 2014-01 2 sitesOther conditions: Heart Defects, Congenital, HyperglycemiaView official trial listing → -
Completed NCT NCT00445913
Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
Not yet reported University of Pittsburgh 10 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00447382
Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 330 participants Est. completion 2008-07 5 sitesOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00449878
Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Not yet reported Anthera Pharmaceuticals 163 participants Est. completion 2008-06 29 sitesOther conditions: Cystic Fibrosis, Exocrine Pancreatic InsufficiencyView official trial listing → -
Completed NCT NCT00456300
Role of Exenatide in Type 1 Diabetes
Not yet reported Montefiore Medical Center 11 participants Est. completion 2009-03 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Terminated NCT NCT00464854
Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward
Not yet reported Assaf-Harofeh Medical Center 100 participants Est. completion 2006-09 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00469092
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 480 participants Est. completion 2008-04 69 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00480584
A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 20 participants Est. completion 2012-11 1 siteOther conditions: Metastatic Pancreatic CarcinomaView official trial listing → -
Completed NCT NCT00489515
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Wake Forest University Health Sciences 115 participants Est. completion 2010-08 1 siteOther conditions: Colorectal Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine CancerView official trial listing → -
Completed NCT NCT00497224
Phase II Trial of Erlotinib in Advanced Pancreatic Cancer
Not yet reported University Health Network, Toronto 51 participants Est. completion 2013-06 5 sitesOther conditions: Cancer, PancreasView official trial listing → -
Completed NCT NCT00499486
Sirolimus in Treating Patients With Advanced Pancreatic Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47 participants Est. completion 2009-06 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00500084
Phase III ALTU-135 CP Safety Trial
Not yet reported Anthera Pharmaceuticals 39 participants Est. completion 2009-03 11 sitesOther conditions: Exocrine Pancreatic InsufficiencyView official trial listing → -
Terminated NCT NCT00500240
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
Not yet reported M.D. Anderson Cancer Center 52 participants Est. completion 2012-04 1 siteOther conditions: Leukemia, LymphomaView official trial listing → -
Completed NCT NCT00504673
Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 277 participants Est. completion 2006-12 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00511719
Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
Not yet reported Mannkind Corporation 13 participants Est. completion 2005-03Type 2 diabetesView official trial listing → -
Completed NCT NCT00513643
Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses
Not yet reported Profil Institut für Stoffwechselforschung GmbH 16 participants Est. completion 2002-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00521404
Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
Not yet reported Daiichi Sankyo 65 participants Est. completion 2010-08-20 12 sitesOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT00541021
Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Not yet reported Institut Paoli-Calmettes 104 participants 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00541593
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts
Not yet reported Baystate Medical Center 5 participants Est. completion 2011-06 1 siteOther conditions: Pancreatic PseudocystView official trial listing → -
Completed NCT NCT00550836
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
Not yet reported Alliance for Clinical Trials in Oncology 104 participants Est. completion 2013-05 262 sitesOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT00551057
Expression of Inflammatory Proteins in Pancreatic Cancer
University of Zurich 150 participants Est. completion 2012-10 1 siteOther conditions: Pancreatic NeoplasmsView official trial listing → -
Terminated NCT NCT00574275
Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer
Not yet reported Sanofi 546 participants Est. completion 2010-11 24 sitesOther conditions: Pancreatic NeoplasmView official trial listing → -
Completed NCT NCT00574912
Characteristics of Glargine in Type 2 Diabetics
Not yet reported Vanderbilt University Medical Center 20 participants Est. completion 2010-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00591227
Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
Not yet reported Rush University Medical Center 176 participants Est. completion 2009-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00597233
Human Insulin NPH and Insulin Aspart in Type 1 Diabetes
Not yet reported Novo Nordisk A/S 91 participants Est. completion 2002-12 1 siteOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00600626
Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 394 participants Est. completion 2004-07 55 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00619697
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 260 participants Est. completion 2005-03 54 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00622674
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Not yet reported Masonic Cancer Center, University of Minnesota 37 participants Est. completion 2010-02 1 siteOther conditions: Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Pancreatic Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Terminated NCT NCT00627471
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
Not yet reported Sanofi 9 participants 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00628186
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy
Not yet reported Wakayama Medical University 100 participants Est. completion 2008-02 1 siteOther conditions: Pancreatic Cancer, Bile Duct Cancer, Ampullary Cancer, Pancreatitis, Duodenal CancerView official trial listing → -
Terminated NCT NCT00630279
Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Not yet reported Solvay Pharmaceuticals 56 participants Est. completion 2009-03 50 sitesOther conditions: Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisView official trial listing → -
Suspended NCT NCT00637364
High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain
Not yet reported, Not yet reported CMED HIFU Development Corporation 5 participants 1 siteOther conditions: Pain, Pancreatic Adenocarcinoma, Ductal AdenocarcinomaView official trial listing → -
Status unknown NCT NCT00637637
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Not yet reported Oncology Institute of Southern Switzerland 60 participants 3 sitesOther conditions: CancerView official trial listing → -
Completed NCT NCT00638612
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
Not yet reported Candel Therapeutics, Inc. 27 participants Est. completion 2015-06 3 sitesOther conditions: Pancreatic Adenocarcinoma, Pancreatic CancerView official trial listing → -
Completed NCT NCT00640991
REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
Not yet reported Population Health Research Institute 500 participants Est. completion 2010-06 13 sitesCardiovascular disease Other conditions: HyperglycemiaView official trial listing → -
Completed NCT NCT00641407
Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes
Not yet reported University of Campania Luigi Vanvitelli 100 participants Est. completion 2008-03 1 siteType 2 diabetes Other conditions: HypoglycemiaView official trial listing → -
Completed NCT NCT00648102
Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
Not yet reported Celldex Therapeutics 36 participants Est. completion 2009-12 3 sitesOther conditions: Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Bladder Cancer, Ovarian CancerView official trial listing → -
Status unknown NCT NCT00658840
Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma
Not yet reported National Cancer Center, Korea 55 participants Est. completion 2013-06 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00662675
A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40 participants Est. completion 2009-02 11 sitesOther conditions: Exocrine Pancreatic Insufficiency, Steatorrhea, Malabsorption Syndromes, Cystic FibrosisView official trial listing → -
Terminated NCT NCT00678145
Mechanisms of Hypoglycemia Associated Autonomic Failure
Not yet reported Albert Einstein College of Medicine 39 participants Est. completion 2018-08 1 siteOther conditions: Diabetes Mellitus, Hypoglycemia, Autonomic FailureView official trial listing → -
Completed NCT NCT00708604
Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes
Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00711997
Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer
Not yet reported, Not yet reported Anchiano Therapeutics Israel Ltd. 9 participants Est. completion 2010-12 4 sitesOther conditions: Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT00712478
Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes
Novo Nordisk A/S 114 participants Est. completion 2009-03 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00715780
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
Novo Nordisk A/S 1667 participants Est. completion 2009-07 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Terminated NCT NCT00753441
Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head
Not yet reported Heidelberg University 24 participants Est. completion 2017-08-16 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00764712
Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients
Not yet reported Charles University, Czech Republic 120 participants Est. completion 2008-04 1 siteOther conditions: HyperglycemiaView official trial listing → -
Completed NCT NCT00771680
Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes
Novo Nordisk A/S 10408 participants Est. completion 2010-07 2 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Terminated NCT NCT00783172
Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer
Not yet reported Milton S. Hershey Medical Center 4 participants Est. completion 2011-10 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00811317
Closed-loop Glucose Control for Automated Management of Type 1 Diabetes
Not yet reported Boston University Charles River Campus 11 participants Est. completion 2009-10 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00821899
Bone Marrow Autotransplantation in Type 1 Diabetes
Not yet reported Hospital Clinic of Barcelona 3 participants Est. completion 2010-05 2 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00849576
Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.
Not yet reported Biodel 15 participants Est. completion 2008-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00882310
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
Not yet reported Columbia University 37 participants Est. completion 2014-10Other conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00889187
Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer
Not yet reported, Not yet reported Dana-Farber Cancer Institute 10 participants Est. completion 2011-12-30 3 sitesOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00899132
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Case Comprehensive Cancer Center 180 participants Est. completion 2012-09 1 siteOther conditions: Non-melanomatous Skin Cancer, Pancreatic Cancer, Small Intestine Cancer, Testicular Germ Cell TumorView official trial listing → -
Completed NCT NCT00909727
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
Not yet reported Vertex Pharmaceuticals Incorporated 52 participants Est. completion 2011-04 29 sitesOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT00913367
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
Not yet reported Handok Inc. 110 participants Est. completion 2010-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00920023
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Not yet reported Massachusetts General Hospital 35 participants Est. completion 2013-02 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00920725
Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA
Not yet reported Rush University Medical Center 50 participants Est. completion 2007-12 1 siteOther conditions: Diabetic KetoacidosisView official trial listing → -
Terminated NCT NCT00923052
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)
National Cancer Institute (NCI) 190 participants Est. completion 2015-05-07 1 siteOther conditions: Hepatic Cancer, Pancreatic Ductal Cancer, Colorectal Cancer, Breast Cancer, Gastric CancerView official trial listing → -
Completed NCT NCT00965718
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer
Not yet reported GC Cell Corporation 20 participants Est. completion 2010-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00983541
Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma
Not yet reported University of Utah 1 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: CancerView official trial listing → -
Completed NCT NCT00994110
Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess
Not yet reported Memorial Sloan Kettering Cancer Center 439 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00995501
The Effects of Corticosteroids, Glucose Control, and Depth-of-Anesthesia on Perioperative Inflammation and Morbidity From Major Non-cardiac Surgery (Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT Trial))
Not yet reported d sessler 381 participants Est. completion 2015-12 1 siteOther conditions: Inflammation, Perioperative MorbidityView official trial listing → -
Completed NCT NCT00998335
Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
Not yet reported University of Florida 30 participants Est. completion 2010-02 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01029639
Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness
Not yet reported, Not yet reported Florida Atlantic University Est. completion 2009-08 1 siteOther conditions: HypoglycemiaView official trial listing → -
Terminated NCT NCT01042028
A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer
Not yet reported, Not yet reported Per Pfeiffer 39 participants Est. completion 2014-01 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01047865
Type 1 Diabetes Recurrence in Pancreas Transplants
University of Miami 238 participants Est. completion 2026-01-05 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01049412
A Study for Patients With Type 1 Diabetes
Not yet reported Eli Lilly and Company 138 participants Est. completion 2011-01 13 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01051284
A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer
Not yet reported Georgetown University 14 participants Est. completion 2012-03 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01062048
Januvia Re-examination Study (MK-0431-181)
Merck Sharp & Dohme LLC 3483 participants Est. completion 2013-07Type 2 diabetesView official trial listing → -
Status unknown NCT NCT01065870
Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)
Not yet reported, Not yet reported Columbia University 64 participants 1 siteOther conditions: Pancreatic Cancer Stage II, Pancreatic Cancer Stage IIIView official trial listing → -
Completed NCT NCT01076647
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 467 participants Est. completion 2010-12 105 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Active, not recruiting NCT NCT01088789
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 71 participants Est. completion 2026-08 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT01103128
Validation of a Mouse Model of Pancreatic Carcinogenesis
Columbia University 450 participants Est. completion 2013-05 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT01116791
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
Not yet reported Baki Topal 34 participants Est. completion 2015-12 1 siteOther conditions: Peritoneal Carcinomatosis, Gastrointestinal CancerView official trial listing → -
Completed NCT NCT01121848
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Not yet reported Sanofi 108 participants Est. completion 2013-10 15 sitesOther conditions: Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT01127269
Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes
Not yet reported Sanofi 178 participants Est. completion 2013-06 23 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT01142050
Stem Cell Therapy for Type 2 Diabetes Mellitus
Not yet reported Cellonis Biotechnology Co. Ltd. 24 participants Est. completion 2011-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01149382
Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients
University of Alberta 61 participants Est. completion 2011-12 1 siteOther conditions: TransplantView official trial listing → -
Completed NCT NCT01153100
Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
Not yet reported University of Colorado, Denver 60 participants Est. completion 2012-02 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01189929
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer
Not yet reported OncoMed Pharmaceuticals, Inc. 57 participants Est. completion 2016-12 6 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01202474
Apidra Children & Adolescents Study
Not yet reported Sanofi 100 participants Est. completion 2012-10 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT01206101
Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
Not yet reported Novo Nordisk A/S 3 participants Est. completion 2013-06-03 16 sitesOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01210911
Metformin Combined With Chemotherapy for Pancreatic Cancer
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120 participants Est. completion 2014-04 1 siteOther conditions: Locally Advanced Pancreatic Cancer, Metastatic Pancreatic CancerView official trial listing → -
Status unknown NCT NCT01218880
Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer
Not yet reported Beijing Protgen Biotechnology Development Co., Ltd. 21 participants Est. completion 2011-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01235039
A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus
Not yet reported, Not yet reported Biodel 43 participants Est. completion 2009-09 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT01267669
A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
Not yet reported Govind Ballabh Pant Hospital 61 participants Est. completion 2009-11 1 siteOther conditions: Acute Bleeding Esophageal Varices, Portal Hypertension, CirrhosisView official trial listing → -
Completed NCT NCT01275131
Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)
Not yet reported Halozyme Therapeutics 45 participants Est. completion 2011-12 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01293396
Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids
Not yet reported Medical University of Graz 20 participants Est. completion 2011-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01315548
Contrast Enhanced Harmonic Endoscopic Ultrasound (CEH-EUS) in Focal Pancreatic Masses
University of Medicine and Pharmacy Craiova 210 participants Est. completion 2012-12 14 sitesOther conditions: Adenocarcinoma Pancreas, Chronic PancreatitisView official trial listing → -
Completed NCT NCT01360593
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Not yet reported David A. Clump, MD, PhD 35 participants Est. completion 2018-10 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01360853
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Not yet reported Traws Pharma, Inc. 160 participants Est. completion 2015-12 46 sitesOther conditions: Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT01399346
Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes
Not yet reported Medical University of Graz 12 participants Est. completion 2011-06 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Not yet reported Massachusetts General Hospital 351 participants Est. completion 2019-12 1 siteOther conditions: Non-small Cell Lung Cancer, Small Cell Lung Cancer, Mesothelioma, Esophageal Cancer, Gastric Cancer, Liver Cancer, Pancreatic CancerView official trial listing → -
Terminated NCT NCT01419002
Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer
Not yet reported CHIR-Net 5 participants Est. completion 2014-10 1 siteOther conditions: Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT01427725
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Mylan Inc. 579 participants Est. completion 2015-04 189 sitesOther conditions: Exocrine Pancreatic Insufficiency, Pancreatic Diseases, Digestive System DiseasesView official trial listing → -
Withdrawn NCT NCT01434550
Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2015-08Other conditions: Pancreatic TumorView official trial listing → -
Status unknown NCT NCT01440439
Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Not yet reported Buckinghamshire Healthcare NHS Trust 30 participants Est. completion 2012-06 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01448070
Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers
Not yet reported Novo Nordisk A/S 28 participants Est. completion 2002-12-20 1 siteOther conditions: Diabetes, HealthyView official trial listing → -
Completed NCT NCT01461577
Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure
Not yet reported Sanofi 89 participants Est. completion 2012-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01464099
Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 24 participants Est. completion 2008-11 1 siteOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01474538
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Not yet reported Eli Lilly and Company 122 participants Est. completion 2013-02 12 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT01522573
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
Weill Medical College of Cornell University 1000 participants Est. completion 2018-12-30 2 sitesOther conditions: Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer, Biliary Stricture, Biliary Obstruction, Stent Obstruction, Proximal Duct Stricture, Distal Duct Stricture, Ampullary Cancer, Biliary Sphincter Stenosis, Impacted Stones, Chronic Pancreatitis, Peri-ampullary Diverticula, Altered AnatomyView official trial listing → -
Completed NCT NCT01530048
Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)
Not yet reported Novo Nordisk A/S 34 participants Est. completion 2006-05 1 siteOther conditions: Diabetes, HealthyView official trial listing → -
Completed NCT NCT01553019
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
Not yet reported University of Florida 2 participants Est. completion 2017-08-31 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01556412
Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis
Tischendorf, Jens, M.D. 32 participants Est. completion 2012-11 1 siteOther conditions: Primary Sclerosing CholangitisView official trial listing → -
Completed NCT NCT01560949
Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas
Not yet reported M.D. Anderson Cancer Center 34 participants Est. completion 2019-02-20 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT01562899
A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
Not yet reported, Not yet reported Pfizer 77 participants Est. completion 2015-04-01 9 sitesOther conditions: Metastatic Pancreatic Adenocarcinoma, BRAF Mutated MelanomaView official trial listing → -
Completed NCT NCT01572740
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 257 participants Est. completion 2013-03-27 23 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01576666
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Not yet reported Novartis Pharmaceuticals 120 participants Est. completion 2015-04 23 sitesOther conditions: Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme, Gastric Cancer, Gastroesophageal Junction Cancer, Triple Negative Metastatic Breast Cancer, Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01593475
Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
Not yet reported National Cancer Center, Korea 44 participants Est. completion 2016-12-31 1 siteOther conditions: Pancreatic Carcinoma Non-resectableView official trial listing → -
Withdrawn NCT NCT01602432
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Ottawa Hospital Research Institute Est. completion 2013-08 1 siteOther conditions: Venous Thromboembolism, Deep-Vein Thrombosis, Pulmonary Embolism, CancerView official trial listing → -
Completed NCT NCT01607996
Effect of Epidural Anesthesia on Pancreatic Perfusion and Clinical Outcome in Patients With Severe Acute Pancreatitis
Not yet reported University Hospital, Geneva 35 participants Est. completion 2011-11 1 siteOther conditions: Severe Acute PancreatitisView official trial listing → -
Completed NCT NCT01618188
A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 52 participants Est. completion 2012-09-07 1 siteOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT01656824
Tissue Study of Bv8/PK-2 Inhibition in Human Cancer
Rambam Health Care Campus 20 participants Est. completion 2014-10 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT01658436
BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.
Not yet reported Novartis Pharmaceuticals 31 participants Est. completion 2015-07 17 sitesOther conditions: Pancreatic Neuroendocrine Tumors (pNET)View official trial listing → -
Completed NCT NCT01682759
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Not yet reported Merck Sharp & Dohme LLC 751 participants Est. completion 2015-01-26Type 2 diabetesView official trial listing → -
Suspended NCT NCT01705899
Islet Allotransplantation in Type 1 Diabetes
Not yet reported Ohio State University 20 participants Est. completion 2033-10 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01719640
MSC and MC in Type 2 Diabetes Mellitus
Not yet reported, Not yet reported Fuzhou General Hospital 22 participants Est. completion 2020-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01729130
Adipose Tissue Function After Pancreas Transplantation
The University of Texas Medical Branch, Galveston 15 participants Est. completion 2019-02-19 1 siteType 2 diabetes Other conditions: Diabetes Mellitus, Type 1, End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT01744353
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Not yet reported Brown University 35 participants Est. completion 2015-08 3 sitesOther conditions: Metastatic Pancreatic CancerView official trial listing → -
Completed NCT NCT01747330
Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency
Not yet reported Abbott Products 40 participants Est. completion 2012-12 9 sitesOther conditions: Pancreatic Exocrine InsufficiencyView official trial listing → -
Completed NCT NCT01755156
A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
Not yet reported Merck Sharp & Dohme LLC 402 participants Est. completion 2016-03-16Type 2 diabetesView official trial listing → -
Completed NCT NCT01774968
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Not yet reported Eli Lilly and Company 325 participants Est. completion 2014-05 39 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01784211
A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 76 participants Est. completion 2013-11 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01796366
A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 40 participants Est. completion 2013-08-19 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01797601
Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application
Not yet reported University Hospital Tuebingen 48 participants Est. completion 2014-04 1 siteOther conditions: Obesity, DiabetesView official trial listing → -
Status unknown NCT NCT01804413
Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Not yet reported Oregon Health and Science University 10 participants Est. completion 2013-12 1 siteOther conditions: Adults Growth Hormone Deficiency.View official trial listing → -
Terminated NCT NCT01851174
Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
Not yet reported Western Regional Medical Center 15 participants Est. completion 2015-01 1 siteOther conditions: Pancreatic Carcinoma Non-resectable, Stage IV Pancreatic CancerView official trial listing → -
Completed NCT NCT01851226
Effect of Different Length of Time for Trainees to Attempt Cannulation on Success Rate of Selective Cannulation During hands-on ERCP Training
Not yet reported Air Force Military Medical University, China 256 participants Est. completion 2013-12 1 siteOther conditions: Disease as Reason for ERCPView official trial listing → -
Terminated NCT NCT01888965
Maintenance Dovitinib for Colorectal and Pancreas Cancer
Not yet reported Georgetown University 9 participants Est. completion 2014-10 1 siteOther conditions: Colorectal Cancer, Pancreas CancerView official trial listing → -
Withdrawn NCT NCT01911416
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
Not yet reported University of Utah Est. completion 2014-10 1 siteOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Available NCT NCT01916148
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Children's Hospital of Philadelphia 1 siteOther conditions: Congenital Hyperinsulinism (CHI), Beckwith-Wiedemann Syndrome, InsulinomaView official trial listing → -
Completed NCT NCT01916265
Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages
Not yet reported Profil Institut für Stoffwechselforschung GmbH 6 participants Est. completion 2013-11 1 siteOther conditions: Diabetes Mellitus Type 1View official trial listing → -
Terminated NCT NCT01956812
Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
Not yet reported Gilead Sciences 334 participants Est. completion 2016-11 64 sitesOther conditions: Metastatic Pancreatic Cancer, Pancreatic CancerView official trial listing → -
Completed NCT NCT01977066
Exercise Intervention Study for Pancreatic Cancer Patients
Not yet reported German Cancer Research Center 65 participants Est. completion 2016-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01978184
Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine
Not yet reported Nathan Bahary, MD 104 participants Est. completion 2018-02-28 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT01989624
PAncreatic Adenocarcinoma in Hospital
Centre Hospitalier Departemental Vendee 1204 participants Est. completion 2020-12 66 sitesOther conditions: Pancreatic AdenocarcinomaView official trial listing → -
Status unknown NCT NCT01992198
Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis
Not yet reported Erzhen Chen 60 participants Est. completion 2016-12 1 siteOther conditions: Pancreatitis,Acute NecrotizingView official trial listing → -
Completed NCT NCT02059161
A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)
Not yet reported Merck Sharp & Dohme LLC 508 participants Est. completion 2015-11-12Other conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT02080650
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
Not yet reported Duke University 62 participants Est. completion 2016-07-19 1 siteOther conditions: Prostate Cancer, Renal Cell Carcinoma, Bladder Cancer, Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Non-small Cell Lung Cancer, Advanced MET Amplified Solid TumorView official trial listing → -
Completed NCT NCT02100475
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
Not yet reported Novo Nordisk A/S 31 participants Est. completion 2015-04 60 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02101580
Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer
Not yet reported Polaris Group 21 participants Est. completion 2017-10-06 1 siteOther conditions: Advanced Pancreatic CancerView official trial listing → -
Completed NCT NCT02108730
Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
University Medicine Greifswald 14 participants Est. completion 2014-03 1 siteOther conditions: Non-focal Congenital HyperinsulinismView official trial listing → -
Completed NCT NCT02127021
The Effects of High Dose Pancreatic Enzyme Replacement Therapy After Pancreatoduodenectomy
Not yet reported Seoul National University Hospital 304 participants Est. completion 2017-12-31 6 sitesOther conditions: PancreaticoduodenectomyView official trial listing → -
Completed NCT NCT02158039
Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms
Not yet reported Mayo Clinic 33 participants Est. completion 2015-09 1 siteOther conditions: Neoplasms, Cystic, Mucinous, and SerousView official trial listing → -
Completed NCT NCT02167074
Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS
Not yet reported Foundation for Liver Research 615 participants Est. completion 2017-06-01 13 sitesOther conditions: Pancreatic Masses, Lymph NodesView official trial listing → -
Terminated NCT NCT02207985
Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma
Not yet reported, Not yet reported Karolinska Institutet 10 participants Est. completion 2017-06-01 1 siteOther conditions: Pancreatic AdenocarcinomaView official trial listing → -
Status unknown NCT NCT02209415
EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer
Not yet reported Michael Bau Mortensen 182 participants Est. completion 2016-08 1 siteOther conditions: Esophageal Cancer, Stomach Cancer, Pancreatic CancerView official trial listing → -
Completed NCT NCT02219750
Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients
Not yet reported Mackay Memorial Hospital 181 participants Est. completion 2016-08 1 siteOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT02220010
Does Post Operative Pancreatic Fistula, After Left Sided Resections, Heal Faster After the Introduction of a Pancreatic Stent?
Not yet reported Karolinska University Hospital 60 participants Est. completion 2017-10 1 siteOther conditions: Healing Time of Post Operative Pancreatic FistulasView official trial listing → -
Status unknown NCT NCT02220062
Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer
Not yet reported Samsung Medical Center 166 participantsOther conditions: Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT02283372
Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
Not yet reported Washington University School of Medicine 30 participants Est. completion 2019-04-18 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT02294474
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
Not yet reported Sanofi 505 participants Est. completion 2016-02 103 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02332863
Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
Not yet reported University of Colorado, Denver 44 participants Est. completion 2020-05-01 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT02345408
Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma
Not yet reported Amgen 54 participants Est. completion 2020-05-06 6 sitesOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT02352831
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Not yet reported, Not yet reported Washington University School of Medicine 16 participants Est. completion 2018-10-19 1 siteOther conditions: Pancreatic Cancer, Cancer of Pancreas, Cancer of the Pancreas, Pancreas CancerView official trial listing → -
Status unknown NCT NCT02355119
Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer
Not yet reported Azienda Ospedaliero, Universitaria Pisana 310 participants Est. completion 2018-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT02356640
EUS-guided CGN for Inoperable Cancer
Not yet reported, Not yet reported Chinese University of Hong Kong 3 participants Est. completion 2019-01-29 1 siteOther conditions: Intractable Abdominal Pain Secondary to Inoperable MalignancyView official trial listing → -
Completed NCT NCT02363777
Paravertebral Catheters for Pancreatic Surgery
Not yet reported University of Minnesota 50 participants Est. completion 2016-06 1 siteOther conditions: Acute PainView official trial listing → -
Completed NCT NCT02370537
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
Not yet reported AstraZeneca 490 participants Est. completion 2015-11 22 sitesType 2 diabetes Other conditions: Exocrine Pancreatic InsufficiencyView official trial listing → -
Completed NCT NCT02402439
Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol
Not yet reported Chuck Rickert, MD, PhD 1 participants Est. completion 2019-04-30 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02428270
A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer
Not yet reported University Health Network, Toronto 16 participants Est. completion 2022-10-27 4 sitesOther conditions: Pancreatic Cancer, AdenocarcinomaView official trial listing → -
Completed NCT NCT02432716
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Not yet reported HealthPartners Institute 12 participants Est. completion 2018-10-18 1 siteOther conditions: Down SyndromeView official trial listing → -
Status unknown NCT NCT02437825
Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery
Not yet reported Hadassah Medical Organization 40 participants Est. completion 2021-06 1 siteOther conditions: Fistula; Salivary Duct or GlandView official trial listing → -
Completed NCT NCT02438189
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms
Not yet reported Jaeb Center for Health Research 33 participants Est. completion 2016-03 3 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02440958
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Not yet reported Yonsei University 50 participants Est. completion 2017-03-02Other conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Completed NCT NCT02453685
A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
Not yet reported Novo Nordisk A/S 335 participants Est. completion 2016-09-20 41 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02463682
Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Not yet reported Sansum Diabetes Research Institute 9 participants Est. completion 2015-10 3 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02464878
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Not yet reported Massachusetts General Hospital 2 participants Est. completion 2022-12 1 siteOther conditions: Kidney Transplant, Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT02479984
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer
Not yet reported National Cancer Center, Korea 193 participants Est. completion 2019-12-31 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT02501902
Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Not yet reported Pfizer 76 participants Est. completion 2018-12-27 26 sitesOther conditions: Metastatic Pancreatic Ductal AdenocarcinomaView official trial listing → -
Status unknown NCT NCT02511951
One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy
Not yet reported The Second Hospital of Anhui Medical University 114 participants Est. completion 2018-12 1 site Stand-aloneOther conditions: Pancreatic FistulaView official trial listing → -
Completed NCT NCT02518945
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
Not yet reported University at Buffalo 26 participants Est. completion 2016-04 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT02525744
A Study of a New LY900014 Formulation in Healthy Participants
Not yet reported Eli Lilly and Company 24 participants Est. completion 2015-10 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
Not yet reported Five Prime Therapeutics, Inc. 313 participants Est. completion 2019-11-18 39 sitesOther conditions: Advanced Solid Tumors, Head and Neck Cancer, Pancreatic Cancer, Ovarian Cancer, Renal Cell Carcinoma, Malignant Glioma, Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT02547519
Pre-POINT-Early Study
Not yet reported Technical University of Munich 44 participants Est. completion 2017-12 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02549937
A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
Not yet reported, Not yet reported Hutchmed 130 participants Est. completion 2023-06-02 12 sitesOther conditions: TumorsView official trial listing → -
Completed NCT NCT02566330
The EndoBarrier Device: A 3-year Follow up Study
Maastricht University Medical Center 10 participants Est. completion 2016-02 1 siteOther conditions: Obesity, DiabetesView official trial listing → -
Withdrawn NCT NCT02575508
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
Not yet reported, Not yet reported Roswell Park Cancer Institute 1 siteOther conditions: Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Rectal Adenocarcinoma, Stage III Pancreatic Cancer, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IV Pancreatic Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal CancerView official trial listing → -
Terminated NCT NCT02590978
Early Cholecystectomy in Patients With Mild Gallstone Acute Pancreatitis
Not yet reported Hospital del Salvador 52 participants Est. completion 2017-11-01 1 siteOther conditions: Gallstone PancreatitisView official trial listing → -
Completed NCT NCT02620553
Primary Intervention With Mucosal Insulin
Not yet reported, Not yet reported University of Colorado, Denver 25 participants Est. completion 2014-01 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02636361
A Study of Various Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 26 participants Est. completion 2016-02 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02644759
Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
Not yet reported, Not yet reported Stem Cells Arabia 100 participants Est. completion 2018-05 1 siteOther conditions: Diabetes Mellitus Type 1, Autoimmune Diseases, Endocrine System Diseases, Glucose Metabolism Disorders, Immune System Diseases, Metabolic DiseasesView official trial listing → -
Status unknown NCT NCT02646462
Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer
Michael Bau Mortensen 200 participants Est. completion 2016-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT02670915
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 834 participants Est. completion 2018-03-03 155 sitesOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT02687230
Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1
Not yet reported BioNTech Research & Development, Inc. 15 participants Est. completion 2017-05-05 1 siteOther conditions: Pancreatic Carcinoma, Tumors That Express CA19-9View official trial listing → -
Completed NCT NCT02690883
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Not yet reported Nanfang Hospital, Southern Medical University 92 participants Est. completion 2019-12-30Other conditions: Diabetic NephropathiesView official trial listing → -
Completed NCT NCT02703337
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02703545
International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs
Johns Hopkins University 58 participants Est. completion 2017-02Other conditions: Pancreas CancerView official trial listing → -
Completed NCT NCT02709421
Risk Factors of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin
Air Force Military Medical University, China 790 participants Est. completion 2016-09 3 sitesOther conditions: HealthyView official trial listing → -
Completed NCT NCT02718859
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Not yet reported, Not yet reported Fuda Cancer Hospital, Guangzhou 60 participants Est. completion 2019-03-01 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT02734680
IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70 participants Est. completion 2019-02 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT02749890
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Not yet reported Sanofi 321 participants Est. completion 2018-05 61 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT02751723
Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease
Florian Lordick, MD 500 participants Est. completion 2019-10 21 sitesOther conditions: Cancer Disease, Palliative TherapyView official trial listing → -
Completed NCT NCT02752113
Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
Not yet reported Institut für Pharmakologie und Präventive Medizin 101 participants Est. completion 2019-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02821026
Omental Islet Transplant
Not yet reported, Not yet reported University of Alberta 4 participants Est. completion 2019-11-13 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT02854072
A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
Not yet reported Samsung Pharmaceutical Co., Ltd. 148 participants Est. completion 2018-05 16 sitesOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT02863783
EUS Fiducial for Pancreas Surgery
Not yet reported University of Southern California 20 participants Est. completion 2024-02 1 site Stand-aloneOther conditions: Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT02894944
Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer
Not yet reported Seoul National University Hospital 9 participants Est. completion 2019-04 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT02921100
Comparison of DNA Ploidy and Conventional Cytology
Not yet reported Changhai Hospital 150 participants 1 siteOther conditions: Biopsy, Fine-NeedleView official trial listing → -
Terminated NCT NCT02952859
Impact of Margin-accentuation IRE in Pancreatic Cancer
Insel Gruppe AG, University Hospital Bern 26 participants Est. completion 2020-02-25 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT02969863
The Monitoring Study
Not yet reported Massachusetts General Hospital 27 participants Est. completion 2017-12-28 1 site Stand-aloneOther conditions: Type1diabetesView official trial listing → -
Withdrawn NCT NCT03001505
Registry for Pancreatic Cancer
Duke University Est. completion 2037-04 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03007329
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Not yet reported Medical University of Vienna 34 participants Est. completion 2020-01-16 1 siteType 2 diabetes Other conditions: Steatosis, LiverView official trial listing → -
Completed NCT NCT03016637
Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy
Not yet reported, Not yet reported Odense University Hospital 40 participants Est. completion 2016-12 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03028181
The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Pancreatic Disease
Wroclaw Medical University 34 participants Est. completion 2016-12Other conditions: Acute PancreatitisView official trial listing → -
Completed NCT NCT03064906
Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)
Not yet reported Insulet Corporation 24 participants Est. completion 2017-04-07 3 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Status unknown NCT NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors
Not yet reported Merrimack Pharmaceuticals 34 participants Est. completion 2018-12 5 sitesOther conditions: Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Ovarian Cancer, Pancreatic Ductal Adenocarcinoma, Prostate Adenocarcinoma, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Triple Negative Breast Cancer, Endometrial Carcinoma, Soft Tissue SarcomaView official trial listing → -
Completed NCT NCT03111433
Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus
Not yet reported Ain Shams University 49 participants Est. completion 2018-01-20 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT03122106
Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Not yet reported Washington University School of Medicine 15 participants Est. completion 2022-08-13 2 sitesOther conditions: Pancreatic Cancer, Pancreas Cancer, Cancer of the PancreasView official trial listing → -
Completed NCT NCT03153410
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11 participants Est. completion 2023-08-29 1 site Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03179332
A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump
Not yet reported Adocia 43 participants Est. completion 2017-09-27 1 siteOther conditions: Type1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03187028
Diet and Exercise After Pancreatic Cancer
Not yet reported University of Alabama at Birmingham 15 participants Est. completion 2021-09-30 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT03187951
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
Not yet reported M.D. Anderson Cancer Center 152 participants Est. completion 2026-12-31 1 siteOther conditions: Other Disorders of Glucose Regulation and Pancreatic Internal Secretion, Pancreatic CancerView official trial listing → -
Completed NCT NCT03203434
Non-invasive Detection of Anastomotic Leakage
Amsterdam UMC, location VUmc 66 participants Est. completion 2017-03-01Other conditions: Anastomotic LeakView official trial listing → -
Status unknown NCT NCT03227939
Effects of Combined Surgery on Obstructive Sleep Apnea in Obese Patients: an Open-label Randomized Controlled Clinical Trial
Not yet reported Bing Wang 100 participants Est. completion 2020-05-01 Stand-aloneOther conditions: To Compare the Difference of AHI Variation Between LSG and Combined SurgeryView official trial listing → -
Withdrawn NCT NCT03248271
Effects of Insulin on Hypotension and Sarcopenia
Kenneth Madden Est. completion 2023-01-10 1 siteOther conditions: Diabetes, Sarcopenia, Hypotension, OrthostaticView official trial listing → -
Status unknown NCT NCT03269955
The Effect of Application of TachoSil® in Pancreatoduodenectomy
Not yet reported Asan Medical Center 126 participants Est. completion 2018-05 1 site Stand-aloneOther conditions: Pancreatic Neoplasm, Pancreatic Periampullary Cancer, Pancreatic Bordeline TumorView official trial listing → -
Completed NCT NCT03307148
Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
Not yet reported Barts & The London NHS Trust 29 participants Est. completion 2019-03-19 4 sitesOther conditions: Pancreatic AdenocarcinomaView official trial listing → -
Terminated NCT NCT03307512
PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD
Not yet reported Dance Biopharm Inc. 40 participants Est. completion 2019-08-30 1 siteOther conditions: Safety and TolerabilityView official trial listing → -
Completed NCT NCT03314337
Pancreatic Stent for Distal Pancreatectomy
Not yet reported Ruijin Hospital 120 participants Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Distal PancreatectomyView official trial listing → -
Status unknown NCT NCT03324867
The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 316 participants Est. completion 2023-04Other conditions: Cognitive Decline, Heart Diseases, DeliriumView official trial listing → -
Status unknown NCT NCT03337087
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer
Not yet reported, Not yet reported Academic and Community Cancer Research United 18 participants Est. completion 2025-08-09 3 sitesOther conditions: Metastatic Biliary Tract Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Digestive System Neoplasm, Metastatic Pancreatic Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IV Pancreatic Cancer AJCC v6 and v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7View official trial listing → -
Withdrawn NCT NCT03348319
Is There a Pancreatic Segmentation Based on the Pancreatic Duct Branching?
CHU de Reims Est. completion 2021-04-01Other conditions: PancreasView official trial listing → -
Completed NCT NCT03367390
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
Not yet reported Eli Lilly and Company 30 participants Est. completion 2018-02-09 1 siteOther conditions: Type1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03368807
Assessment of Mealtime Bolus Insulin Behavior
Eli Lilly and Company 79 participants Est. completion 2018-07-23 6 sitesType 2 diabetes Other conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03371082
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Not yet reported Gan and Lee Pharmaceuticals, USA 576 participants Est. completion 2019-08-19 85 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT03374293
Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer
Not yet reported Shixiu Wu 21 participants Est. completion 2021-12-31 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03407118
A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 31 participants Est. completion 2018-07-12 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03407599
A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 46 participants Est. completion 2018-07-05 1 siteOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03415802
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
Not yet reported Aiping Zhou 32 participants Est. completion 2019-07-11 1 siteOther conditions: Advanced Pancreatic CancerView official trial listing → -
Suspended NCT NCT03417921
A Study of ABTL0812 in Pancreatic Cancer
Not yet reported, Not yet reported Ability Pharmaceuticals SL 60 participants Est. completion 2025-12-31 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03424044
Three Way Crossover Closed Loop Study With Xeris Glucagon
Not yet reported Oregon Health and Science University 23 participants Est. completion 2019-05-17 1 site Stand-aloneOther conditions: Type1diabetesView official trial listing → -
Status unknown NCT NCT03447691
Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery
Not yet reported Yonsei University 132 participants Est. completion 2022-08-28 1 siteOther conditions: Pancreatic Cancer or Distal CBD CancerView official trial listing → -
Terminated NCT NCT03472833
High-dose Vitamin D3 in Pancreas Cancer
Not yet reported Medical University of Graz 25 participants Est. completion 2021-04-20 1 siteOther conditions: Pancreas Cancer, Vitamin D Deficiency, Quality of LifeView official trial listing → -
Status unknown NCT NCT03500068
Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30 participants Est. completion 2022-09-01 1 siteOther conditions: Carcinoma, Pancreatic DuctalView official trial listing → -
Completed NCT NCT03510078
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
Not yet reported Rabin Medical Center 600 participants Est. completion 2025-12-10 5 sitesOther conditions: Diabetes Mellitus, Non-critically Ill PatientsView official trial listing → -
Completed NCT NCT03513705
Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 4000 participants Est. completion 2021-07-09 17 sitesOther conditions: Carcinoma, Pancreatic DuctalView official trial listing → -
Completed NCT NCT03551691
Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)
Not yet reported Children's Hospital of Philadelphia 19 participants Est. completion 2022-11-02 1 siteOther conditions: Pancreatic Insufficiency, Cystic FibrosisView official trial listing → -
Completed NCT NCT03611556
MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.
Not yet reported, Not yet reported MedImmune LLC 213 participants Est. completion 2022-07-22 27 sitesOther conditions: Carcinoma, Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT03616431
Pancreatic Cancer Dietary Assessment Study
The Christie NHS Foundation Trust 112 participants Est. completion 2021-05-31 1 siteOther conditions: Pancreatic Neoplasm, Pancreas Adenocarcinoma, Well-Differentiated Neuroendocrine Carcinoma, Malignant Neoplasm of PancreasView official trial listing → -
Status unknown NCT NCT03621852
Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)
Philipps University Marburg 40 participants Est. completion 2020-07-01 1 siteObstructive sleep apnea Other conditions: Tumors of the Pancreas, Lymph Node DiseaseView official trial listing → -
Status unknown NCT NCT03650582
Intranasal Glucagon and Energy Balance
Not yet reported, Not yet reported University Health Network, Toronto 20 participants Est. completion 2018-10-30 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT03662412
Study of Sirolimus in Patients With Advanced Pancreatic Cancer
Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 36 participants Est. completion 2023-06-30 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT03693677
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI
Not yet reported Federation Francophone de Cancerologie Digestive 288 participants Est. completion 2025-01-10 36 sitesOther conditions: Metastatic Pancreatic CancerView official trial listing → -
Withdrawn NCT NCT03707444
A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2019-11-26 1 siteOther conditions: Cancer Pancreas, Pain Syndrome, Cancer Related PainView official trial listing → -
Completed NCT NCT03714594
Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.
Not yet reported University of Pisa 48 participants Est. completion 2022-08-31 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03738865
G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes
Not yet reported Xeris Pharmaceuticals 132 participants Est. completion 2019-04-02 7 sitesOther conditions: Insulin Hypoglycemia, Type 1 Diabetes Mellitus, Severe HypoglycemiaView official trial listing → -
Completed NCT NCT03760991
Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin
Not yet reported Sanofi 372 participants Est. completion 2020-09-23 14 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT03770559
The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients
Not yet reported Peking Union Medical College Hospital 125 participants Est. completion 2024-12-30 1 siteOther conditions: Pancreatic Cancer, SurgeryView official trial listing → -
Active, not recruiting NCT NCT03785249
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
Not yet reported, Not yet reported Mirati Therapeutics Inc. 731 participants Est. completion 2026-12-31 222 sitesOther conditions: Advanced Cancer, Metastatic Cancer, Malignant Neoplastic DiseaseView official trial listing → -
Status unknown NCT NCT03788928
Predicting Pancreatic Necrosis Using mitDNA
Assiut University 25 participants Est. completion 2020-12Other conditions: Pancreatic NecrosisView official trial listing → -
Approved For Marketing NCT NCT03791567
Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
CellTrans Inc. 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03808272
AXIOS CHINA (E7148)
Not yet reported Boston Scientific Corporation 31 participants Est. completion 2021-10-30 1 siteOther conditions: Pancreatic Pseudocyst and Walled-off NecrosisView official trial listing → -
Status unknown NCT NCT03809247
Microbial Diversity of Pancreatic Diseases
Ruijin Hospital 330 participants Est. completion 2025-12-31 1 siteOther conditions: Pancreatic Cancer, Pancreatic DiseaseView official trial listing → -
Completed NCT NCT03829891
Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus
Not yet reported Xijing Hospital 60 participants Est. completion 2020-12-04 2 sitesType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT03862911
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
Not yet reported British Columbia Cancer Agency 330 participants Est. completion 2030-12-31 17 sites Stand-aloneOther conditions: Metastatic TumorsView official trial listing → -
Status unknown NCT NCT03865875
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program
Not yet reported Massachusetts General Hospital 40 participants Est. completion 2024-08 1 siteOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Completed NCT NCT03891472
Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer
Not yet reported Medical University of Silesia 40 participants Est. completion 2019-07-31 1 siteOther conditions: Cancer of Pancreas, Unresectable Pancreatic Cancer, Chemotherapy Effect, SBRTView official trial listing → -
Completed NCT NCT03965013
A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes
Not yet reported Novo Nordisk A/S 78 participants Est. completion 2019-12-14 1 siteOther conditions: Diabetes Mellitus, Type 1, Healthy VolunteersView official trial listing → -
Status unknown NCT NCT03986294
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122 participants Est. completion 2022-01-01 1 siteOther conditions: Metastatic Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT03991962
Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma
Not yet reported Yale University 28 participants Est. completion 2027-02 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT04012138
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
Not yet reported Nantes University Hospital 419 participants Est. completion 2025-12-20 16 sitesOther conditions: HyperkalemiaView official trial listing → -
Status unknown NCT NCT04014192
Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus
Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2020-07-31 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT04021277
PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin
Not yet reported EXACT Therapeutics AS 11 participants Est. completion 2024-09-24 4 sitesOther conditions: Solid Tumor, Colorectal CancerView official trial listing → -
Completed NCT NCT04031599
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
Not yet reported Institut de Recherches Cliniques de Montreal 30 participants Est. completion 2021-12-14 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Withdrawn NCT NCT04037241
Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases
Not yet reported, Not yet reported Sorrento Therapeutics, Inc. Est. completion 2022-01-01Other conditions: Malignant Tumor of Pancreas Metastatic to LiverView official trial listing → -
Completed NCT NCT04080024
A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer
Not yet reported Spago Nanomedical AB 14 participants Est. completion 2022-11-30 2 sitesOther conditions: Breast Cancer, Pancreas CancerView official trial listing → -
Status unknown NCT NCT04107428
Somatostatin in Living Donor Liver Transplantation
Not yet reported King Faisal Specialist Hospital & Research Center 56 participants Est. completion 2022-02Other conditions: End Stage Liver DIsease, Portal HypertensionView official trial listing → -
Status unknown NCT NCT04115527
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
Not yet reported Ruijin Hospital 100 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Completed NCT NCT04128332
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer
Not yet reported CCTU- Cancer Theme 10 participants Est. completion 2025-01-11 1 siteOther conditions: Cancer of PancreasView official trial listing → -
Completed NCT NCT04130685
Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients
Rush University Medical Center 48 participants Est. completion 2022-12-01 1 siteOther conditions: Pancreas Transplant Rejection, Kidney Transplant RejectionView official trial listing → -
No Longer Available NCT NCT04137822
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
Impatients N.V. trading as myTomorrows 2 sitesOther conditions: Pancreas Cancer, Pancreatic Cancer, Pancreatic Cancer Stage IV, Pancreatic Cancer Stage IIIView official trial listing → -
Completed NCT NCT04142229
Artificial Pancreas With Different Stress Assessments in the Outpatient Setting
Not yet reported Sansum Diabetes Research Institute 14 participants Est. completion 2020-11-06 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT04148755
The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions
Assiut University 100 participants Est. completion 2021-10-30 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT04157738
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
Not yet reported Emory University 24 participants Est. completion 2020-12-17 1 siteOther conditions: Diabetes Mellitus, Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT04158414
Applying PET/MR in Oncology - a Prospective Project
Not yet reported Tel-Aviv Sourasky Medical Center 500 participants Est. completion 2021-11-28Other conditions: Lymphoma, Nasopharyngeal Cancer, Esophageal Cancer, Cervical Cancer, Hepatobiliary Cancer, Pancreatic Cancer, Sarcoma, Prostate CancerView official trial listing → -
Terminated NCT NCT04171700
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
Not yet reported pharmaand GmbH 83 participants Est. completion 2022-07-15 19 sitesOther conditions: Solid TumorView official trial listing → -
Terminated NCT NCT04176952
PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer
Not yet reported Judith Dixon-Hughes 31 participants Est. completion 2021-08-19 3 sitesOther conditions: Neoplasms PancreaticView official trial listing → -
Status unknown NCT NCT04203459
The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation
First Affiliated Hospital of Harbin Medical University 80 participants Est. completion 2022-12-31 1 siteOther conditions: Pancreatic Cancer, Gut Microbiota, CAR-TView official trial listing → -
Terminated NCT NCT04203641
L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer
Not yet reported, Not yet reported Helix BioPharma Corporation 28 participants Est. completion 2024-10-24 3 sitesOther conditions: Pancreas CancerView official trial listing → -
Completed NCT NCT04207060
Trial of Indomethacin in Chronic Pancreatitis
Not yet reported, Not yet reported Mayo Clinic 27 participants Est. completion 2023-04-24 2 sitesOther conditions: Chronic PancreatitisView official trial listing → -
Status unknown NCT NCT04243629
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
Not yet reported McGill University 26 participants Est. completion 2024-04 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial HyperglycemiaView official trial listing → -
Status unknown NCT NCT04245644
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study
Massimo Falconi 800 participants Est. completion 2024-12-31 1 siteOther conditions: Disease Free Survival, Overall Survival, Pancreatic CancerView official trial listing → -
Status unknown NCT NCT04266379
Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia
Not yet reported University Hospital, Montpellier 72 participants Est. completion 2023-02-03 2 sitesOther conditions: Type 1 Diabetes Mellitus With HypoglycemiaView official trial listing → -
Completed NCT NCT04330716
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
Not yet reported Dana-Farber Cancer Institute 269 participants Est. completion 2023-12-31 6 sitesOther conditions: Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Metastatic Prostate CancerView official trial listing → -
Status unknown NCT NCT04335474
Surgical Versus Percutaneous Drainage in the Management of High Grade Pancreatic Trauma
Nanjing PLA General Hospital 80 participants Est. completion 2023-03-31 1 siteOther conditions: Trauma, Pancreatic TraumaView official trial listing → -
Active, not recruiting NCT NCT04404595
Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
Not yet reported, Not yet reported CARsgen Therapeutics Co., Ltd. 110 participants Est. completion 2035-09-01 16 sitesOther conditions: Gastric Cancer, Pancreatic CancerView official trial listing → -
Status unknown NCT NCT04425876
A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 74 participants Est. completion 2023-09-01 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT04431258
ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study
Not yet reported, Not yet reported Ability Pharmaceuticals SL 150 participants Est. completion 2024-01-10 24 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT04440306
"Tailored" Bilio-Pancreatic Limb Length and Weight Loss After Mini-Gastric Bypass
Kular Hospital 191 participants Est. completion 2020-02-01 1 siteOther conditions: Obesity, Morbid, Weight Loss, Bariatric Surgery Candidate, PowerView official trial listing → -
Active, not recruiting NCT NCT04472910
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
Not yet reported University Health Network, Toronto 84 participants Est. completion 2026-12 8 sitesOther conditions: Resectable Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT04482309
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
Not yet reported AstraZeneca 477 participants Est. completion 2027-03-23 89 sitesOther conditions: Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerView official trial listing → -
Completed NCT NCT04537923
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
Not yet reported Eli Lilly and Company 1428 participants Est. completion 2022-11-01 135 sitesType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT04542148
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
Not yet reported University of Alabama at Birmingham 120 participants Est. completion 2026-12-31 4 sitesType 2 diabetes Other conditions: Preterm Birth, Pregnancy, High Risk, Diabetes, GestationalView official trial listing → -
Active, not recruiting NCT NCT04560712
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
Not yet reported M.D. Anderson Cancer Center 70 participants Est. completion 2027-12-31 1 siteOther conditions: Resectable Colorectal Carcinoma, Resectable Digestive System Carcinoma, Resectable Pancreatic CarcinomaView official trial listing → -
Completed NCT NCT04591626
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
Not yet reported Eli Lilly and Company 291 participants Est. completion 2022-04-28 27 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT04617821
AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer
Not yet reported Fudan University 300 participants Est. completion 2024-09 1 siteOther conditions: Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic AdenocarcinomaView official trial listing → -
Status unknown NCT NCT04636788
Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer
Not yet reported Huazhong University of Science and Technology 102 participants Est. completion 2022-11-01 1 siteOther conditions: Pancreas AdenocarcinomaView official trial listing → -
Completed NCT NCT04666688
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Not yet reported, Not yet reported PureTech 44 participants Est. completion 2024-12-12 12 sitesOther conditions: Metastatic Cancer, Solid Tumor, Pancreatic Cancer, Urothelial Carcinoma, Head and Neck Cancer, Colorectal CancerView official trial listing → -
Completed NCT NCT04672642
Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations
Not yet reported Hospital St. Joseph, Marseille, France 27 participants Est. completion 2024-03-13 1 siteOther conditions: Pancreatitis, ChronicView official trial listing → -
Terminated NCT NCT04683939
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
Not yet reported, Not yet reported BioNTech SE 13 participants Est. completion 2023-07-24 7 sitesOther conditions: Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma, Pancreatic Cancer, Biliary Tract Cancer, Cholangiocarcinoma, Metastatic CancerView official trial listing → -
Completed NCT NCT04701424
Closed-loop in Adults With T2D Not Requiring Dialysis
Not yet reported University of Cambridge 30 participants Est. completion 2022-03-30 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04705818
Combining Epigenetic And Immune Therapy to Beat Cancer.
Not yet reported Institut Bergonié 164 participants Est. completion 2025-07-17 3 sitesOther conditions: Advanced Solid Tumor, Advanced Colorectal Carcinoma, Advanced Soft-tissue Sarcoma, Advanced Pancreatic Adenocarcinoma, Adult Solid TumorView official trial listing → -
Status unknown NCT NCT04718701
Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer
Not yet reported The First Affiliated Hospital with Nanjing Medical University 53 participants Est. completion 2023-02-01 1 siteOther conditions: Pancreatic Neoplasm, Metastatic Pancreatic Cancer, Locally Advanced Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT04742023
Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal Transplantation
Not yet reported Northwell Health 40 participants Est. completion 2023-12-21 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT04747600
Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.
Zagazig University 63 participants Est. completion 2021-01-01Other conditions: Pancreas CancerView official trial listing → -
Status unknown NCT NCT04773769
Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas
Not yet reported Auxilio Mutuo Cancer Center 54 participants Est. completion 2023-11 1 siteOther conditions: Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, Low Grade Lymphoma, Colorectal AdenocarcinomaView official trial listing → -
Completed NCT NCT04783376
Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
Not yet reported Sohag University 43 participants Est. completion 2022-03-03 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT04789980
Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY
Boryung Pharmaceutical Co., Ltd 799 participants Est. completion 2025-06-24 1 siteOther conditions: Locally Advanced Pancreatic Cancer, Metastatic Pancreatic CancerView official trial listing → -
Completed NCT NCT04793165
Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting
Not yet reported Hospital Italiano de Buenos Aires 5 participants Est. completion 2021-04-08 1 siteOther conditions: Type 1 Diabetes, Autoimmune DiabetesView official trial listing → -
Active, not recruiting NCT NCT04793932
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)
Not yet reported Associazione Italiana per lo Studio del Pancreas 261 participants Est. completion 2026-01-31 22 sitesOther conditions: Pancreas Ductal AdenocarcinomaView official trial listing → -
Status unknown NCT NCT04814251
Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study
Poitiers University Hospital 200 participants Est. completion 2024-12Other conditions: Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT04880850
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Not yet reported Novo Nordisk A/S 582 participants Est. completion 2022-06-16 116 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT04907851
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Not yet reported Redx Pharma Ltd 45 participants Est. completion 2023-11-30 13 sitesOther conditions: Advanced Solid TumoursView official trial listing → -
Terminated NCT NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
Not yet reported University of Oklahoma 25 participants Est. completion 2026-04-03 1 siteOther conditions: Exocrine Pancreatic CancerView official trial listing → -
Completed NCT NCT04957914
A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus
Not yet reported Eli Lilly and Company 54 participants Est. completion 2022-10-17 1 site Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT04989868
Effect of Trans-Nasal Afferent Loop Decompression on Post-Pancreaticoduodenectomy Pancreatic Fistula
Not yet reported The First Affiliated Hospital with Nanjing Medical University 299 participants Est. completion 2022-11-12 1 siteOther conditions: Pancreatic Fistula, Pancreaticoduodenectomy, Complication of Surgical ProcedureView official trial listing → -
Status unknown NCT NCT05051358
Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University 5000 participants Est. completion 2023-12-10 1 siteOther conditions: Therapeutic Endoscopic Ultrasound, Advanced Endoscopy, Therapeutic Endoscopy, Interventional Endoscopy, Interventional Endoscopic Ultrasound, Gastro-Intestinal Disorder, Gastrointestinal Disease, Gastrointestinal Cancer, Gastrointestinal Dysfunction, Gastrointestinal Fistula, Gastrointestinal Infection, Gastrointestinal Injury, Pancreatic Disease, Bile Duct DiseasesView official trial listing → -
Status unknown NCT NCT05064618
Investigator-initiated Clinical Trial of MIKE-1
Not yet reported, Not yet reported Nagoya University 55 participants Est. completion 2025-04-30 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT05075564
A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors
Not yet reported Elpiscience Biopharma, Ltd. 8 participants Est. completion 2022-10-13 7 sitesOther conditions: Advanced Solid TumorView official trial listing → -
Completed NCT NCT05085548
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Not yet reported ProDa BioTech, LLC 46 participants Est. completion 2026-04-10 1 siteOther conditions: Advanced Pancreatic Cancer, Solid Tumor MalignanciesView official trial listing → -
Status unknown NCT NCT05095064
Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan
University Hospital, Antwerp 60 participants Est. completion 2022-03-01 1 siteOther conditions: Metastatic Pancreatic Ductal AdenocarcinomaView official trial listing → -
Status unknown NCT NCT05147168
Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan
Taipei Veterans General Hospital, Taiwan 300 participants Est. completion 2024-11-22 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT05161013
A Proof-of-Concept Study Evaluating LINFU™
Not yet reported Adenocyte, LLC 12 participants Est. completion 2023-10-30 1 site Stand-aloneOther conditions: Pancreas Adenocarcinoma, DysplasiaView official trial listing → -
Status unknown NCT NCT05185869
SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
Not yet reported Ruijin Hospital 58 participants Est. completion 2025-10 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT05226572
Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results
University of Bologna 462 participants Est. completion 2022-05-23 1 siteOther conditions: Pancreatic Adenocarcinoma, Pancreas Cancer, Pancreas MetastasesView official trial listing → -
Completed NCT NCT05262387
A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 25 participants Est. completion 2023-03-07 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT05286827
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Not yet reported National Cancer Institute (NCI) 5 participants Est. completion 2025-09-25 1 siteOther conditions: Pancreatic Acinar Cell CarcinomaView official trial listing → -
Completed NCT NCT05289362
Comparison of Efficacy of Basket and Balloon in the Removal of Pancreatic Duct Stones in Chronic Pancreatitis Under ERCP
Not yet reported Changhai Hospital 104 participants Est. completion 2023-03-12 1 siteOther conditions: Pancreatitis, Chronic, Pancreatic Duct StoneView official trial listing → -
Status unknown NCT NCT05327400
Expression and Clinical Significance of IGHD in Pancreatic Cancer
Affiliated Hospital of Nantong University 30 participants Est. completion 2023-10-31 1 siteOther conditions: Gene ExpressionView official trial listing → -
Completed NCT NCT05383352
A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas
Not yet reported Ipsen 177 participants Est. completion 2025-04-15 36 sitesOther conditions: Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT05395013
Efficacy and Safety of Plastic, Covered and Uncovered Self-expandable Metal Stents in the Treatment of Malignant Biliary Obstructions (NEOSTENT)
Azienda Unità Sanitaria Locale della Romagna 3149 participants Est. completion 2022-05-31 1 siteOther conditions: Common Bile Duct Stricture, Jaundice; MalignantView official trial listing → -
Withdrawn NCT NCT05415917
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy
Not yet reported Rutgers, The State University of New Jersey Est. completion 2024-08-05 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Status unknown NCT NCT05448729
Shear Wave Elastography Versus Strain Elastography With Histogram Analysis in Solid Pancreatic Lesions
Not yet reported Iuliu Hatieganu University of Medicine and Pharmacy 100 participants Est. completion 2023-06-15Other conditions: Endoscopic UltrasonographyView official trial listing → -
Status unknown NCT NCT05463445
Multicenter Observational Study of PSC and IgG4-SC in China
RenJi Hospital 1000 participants Est. completion 2023-07-31 1 siteOther conditions: Primary Sclerosing Cholangitis, IgG4-related Sclerosing CholangitisView official trial listing → -
Completed NCT NCT05520606
Laparoscopic Pancreatoduodenectomy Versus Open Pancreatoduodenectomy
Tongji Hospital 800 participants Est. completion 2021-12-30Other conditions: Resectable Lesions Located in the Pancreatic Head or Periampullary RegionView official trial listing → -
Completed NCT NCT05550480
Effect of Continuous Glucose Monitoring on Hypoglycemia in Adults With Pancreatogenic Diabetes
Not yet reported Aalborg University Hospital 30 participants Est. completion 2024-06-05 1 siteOther conditions: Pancreatogenic Type 3C Diabetes MellitusView official trial listing → -
Terminated NCT NCT05571839
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Not yet reported Seagen, a wholly owned subsidiary of Pfizer 41 participants Est. completion 2026-06-01 37 sitesOther conditions: Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, MesotheliomaView official trial listing → -
Status unknown NCT NCT05580445
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
Not yet reported, Not yet reported Shouyao Holdings (Beijing) Co. LTD 114 participants Est. completion 2024-08-11 1 siteOther conditions: Advanced Pancreatic CancerView official trial listing → -
Completed NCT NCT05586516
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
Not yet reported, Not yet reported iOnctura 16 participants Est. completion 2025-08-18 3 sitesOther conditions: Metastatic Pancreatic CancerView official trial listing → -
Completed NCT NCT05589480
Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection
Luo Cong 226 participants Est. completion 2022-09-01 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT05604560
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
Not yet reported Lei Zheng 25 participants Est. completion 2026-09 2 sitesOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT05644730
Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes
Not yet reported Ideal Medical Technologies 7 participants Est. completion 2024-06-21 1 siteType 2 diabetes Other conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT05702073
To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 423 participants Est. completion 2024-06-11 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT05714475
Pancreas Resection for Colorectal Metastasis: Retrospective Study
Ospedale Generale Di Zona Moriggia-Pelascini 15 participants Est. completion 2023-06-30 1 siteOther conditions: Pancreas Metastases, Colorectal CancerView official trial listing → -
Completed NCT NCT05780151
Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)
Not yet reported Mira Zuidgeest 107 participants Est. completion 2025-01-21 9 sitesType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT05874726
Biological Sample Repository for Gastrointestinal Disorders
Pichamol Jirapinyo, MD, MPH 500 participants Est. completion 2029-04 1 siteType 2 diabetes Other conditions: Obesity, Obesity, Morbid, Obesity, Primary, Gastro-Intestinal Disorder, Overweight and Obesity, Overweight, Overweight or Obesity, Diabetes Type 2, Diabetes Mellitus, Hypertension, Hyperlipidemias, Sleep Apnea, GERD, Gastroesophageal Reflux, Musculoskeletal Pain Disorder, CancerView official trial listing → -
Not yet recruiting NCT NCT05894811
A Study on the Effect of Bariatric Surgery on Glucose Metabolism in Chinese Obese and Type 2 Diabetes Patients
Dongyang Liu 48 participants Est. completion 2026-12-01Other conditions: Diabete Type 2, ObesityView official trial listing → -
Status unknown NCT NCT05923567
New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase
Gangnam Severance Hospital 150 participants Est. completion 2024-12-31 1 siteOther conditions: Paancreatic CancerView official trial listing → -
Completed NCT NCT05936203
Management of Prolonged Aerobic exeRcise in Patients With Type 1 Diabetes on Advanced Technologies
Not yet reported Federico II University 18 participants Est. completion 2024-02-15 1 siteOther conditions: Type1diabetesView official trial listing → -
Enrolling by invitation NCT NCT05947825
Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients
Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2026-09 1 siteOther conditions: PDAC - Pancreatic Ductal AdenocarcinomaView official trial listing → -
Not yet recruiting NCT NCT05988372
Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)
Not yet reported Sun Yat-sen University 50 participants Est. completion 2026-10-23 1 siteOther conditions: Locally Advanced Pancreatic CancerView official trial listing → -
Status unknown NCT NCT05989724
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Not yet reported Qurgen Inc. 150 participants Est. completion 2026-03 5 sitesOther conditions: Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer, Colorectal CancerView official trial listing → -
Active, not recruiting NCT NCT06001268
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 80 participants Est. completion 2027-08 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Withdrawn NCT NCT06054308
Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study
Not yet reported Chinese University of Hong Kong Est. completion 2026-08-02 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT06093009
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer
National Cheng-Kung University Hospital 208 participants Est. completion 2023-06 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Withdrawn NCT NCT06110598
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
Not yet reported Case Comprehensive Cancer Center Est. completion 2027-12-31 1 siteOther conditions: Pancreas Cancer, Pancreas AdenocarcinomaView official trial listing → -
Not yet recruiting NCT NCT06133023
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts
Not yet reported Tokyo University 80 participants Est. completion 2033-09 26 sitesOther conditions: Pancreatic Fluid Collection, Pancreatitis, Pancreatic PseudocystView official trial listing → -
Completed NCT NCT06153329
A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese Subjects
Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 39 participants Est. completion 2022-06-06 1 siteOther conditions: HealthyView official trial listing → -
Not yet recruiting NCT NCT06166589
Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer
Not yet reported Shanghai Zhongshan Hospital 19 participants Est. completion 2027-01-01 1 siteOther conditions: Previously AG Chemotherapy Treated Pancreatic CancerView official trial listing → -
Not yet recruiting NCT NCT06167421
Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy
Not yet reported Fudan University 240 participants Est. completion 2027-12-31 Stand-aloneOther conditions: Pancreatic Tumor, Benign, Pancreatic Neuroendocrine Tumor, Solid Pseudopapillary Tumor of the PancreasView official trial listing → -
Status unknown NCT NCT06202014
Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43 participants Est. completion 2025-12-31 1 siteOther conditions: Pancreatic Cancer, Radiotherapy, Envafolimab, CapecitabineView official trial listing → -
Not yet recruiting NCT NCT06203821
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Not yet reported Aram Hezel 25 participants Est. completion 2032-09-30 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Suspended NCT NCT06211933
Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)
Not yet reported, Not yet reported Centre Leon Berard 26 participants Est. completion 2030-02 1 siteOther conditions: Non-Resectable Pancreas CarcinomaView official trial listing → -
Status unknown NCT NCT06289530
Association Between Perioperative Blood and Interstitial Fluid Glucose Level and Clinically Relevant Postoperative Pancreatic Fistula in Different Pancreatic Surgeries
Peking Union Medical College Hospital 600 participants Est. completion 2025-04-30 1 siteOther conditions: Postoperative Pancreatic FistulaView official trial listing → -
Active, not recruiting NCT NCT06305286
Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
Not yet reported, Not yet reported University of Chicago 70 participants Est. completion 2029-03 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT06315647
Comparison Between Different Techniques in Difficult CBD Cannulation
Not yet reported Menoufia University 150 participants Est. completion 2023-11-20 1 siteOther conditions: ERCP, Difficult CBD CannulationView official trial listing → -
Status unknown NCT NCT06319755
Characteristics of Intestinal Microbiome Following Pancreatic Surgery
Royal Prince Alfred Hospital, Sydney, Australia 20 participants Est. completion 2025-08 1 siteOther conditions: Pancreatic Cancer, Microbiota, PancreatoduodenectomyView official trial listing → -
Status unknown NCT NCT06345300
NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40 participants Est. completion 2025-12-24 1 siteOther conditions: Borderline Resectable Pancreatic CancerView official trial listing → -
Completed NCT NCT06358001
EchoTip AcuCore Post-Market Clinical Study
Cook Research Incorporated 183 participants Est. completion 2025-07-19 8 sitesOther conditions: Adenocarcinoma, Neuroendocrine Tumors, Hepatocellular Carcinoma, Cholangiocarcinoma, Malignant Lymphoma, Metastasis, Chronic Pancreatitis, Autoimmune PancreatitisView official trial listing → -
Completed NCT NCT06378047
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 2 participants Est. completion 2025-09-15 1 siteOther conditions: Pancreatic Cancer, Locally Advanced Pancreatic CancerView official trial listing → -
Not yet recruiting NCT NCT06387368
Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
Not yet reported Xi'an Jiaotong University 488 participants Est. completion 2028-08Other conditions: Pancreatic Cancer Non-resectableView official trial listing → -
Status unknown NCT NCT06400082
Topical Insulin for Postoperative Wound Healing
Not yet reported Cairo University 74 participants Est. completion 2024-12-10 1 siteOther conditions: Wound Complication, Insulin Resistance, DiabetesView official trial listing → -
Status unknown NCT NCT06405685
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-10-30 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT06426160
Tocilizumab for Painful Chronic Pancreatitis
Not yet reported Soren Schou Olesen 32 participants Est. completion 2026-10 1 siteOther conditions: Pancreatitis, ChronicView official trial listing → -
Status unknown NCT NCT06499792
Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic Duodenopancreatectomy
University Hospital, Strasbourg, France 160 participants Est. completion 2024-12-31 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Enrolling by invitation NCT NCT06512818
Effect of Psiguavin for Obesity Treatment (PSIGUAVIN)
Not yet reported, Not yet reported Universidad Católica San Antonio de Murcia 100 participants Est. completion 2027-12-19 1 siteOther conditions: Obesity, Overweight or ObesityView official trial listing → -
Not yet recruiting NCT NCT06550973
PROceeding With Advanced Techniques in Case of Distal Malignant Biliary Obstruction and Difficult Biliary Cannulation comparEd With Therapeutic-EUS: the PROMETHEUS Trial
Not yet reported Istituto Clinico Humanitas 220 participants Est. completion 2026-09-30Other conditions: Malignant Biliary ObstructionView official trial listing → -
Withdrawn NCT NCT06554730
MSD Belzutifan PAS
Merck Sharp & Dohme LLC Est. completion 2030-12-31Other conditions: Von Hippel Lindau DiseaseView official trial listing → -
Completed NCT NCT06557408
Pancreatic Fistula After Minimally Invasive Enucleation
Fudan University 173 participants Est. completion 2024-07-30 1 siteOther conditions: Pancreatic Tumor, Benign, Pancreatic Neuroendocrine Tumor, Solid Pseudopapillary Tumor of the PancreasView official trial listing → -
Status unknown NCT NCT06558708
A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD
Not yet reported Gan and Lee Pharmaceuticals, USA 60 participants Est. completion 2024-12 1 siteType 2 diabetesView official trial listing → -
Enrolling by invitation NCT NCT06645223
Correlation Between Gut Microbiota and Pancreatic Β-Cell Function in Diabetic Patients
Peking University Third Hospital 160 participants Est. completion 2026-07-01 1 siteOther conditions: Diabetes Mellitus, Gut MicrobiotaView official trial listing → -
Not yet recruiting NCT NCT06672601
Intra-abdominal Hypertension and Abdominal Compartment Syndrome in Patients After Pancreatic Procedures.
Charles University, Czech Republic 150 participants Est. completion 2028-03-31 1 siteOther conditions: Intra Abdominal Pressure, Abdominal Compartment Syndrome, Pancreatic Surgery, Pancreatic Fistula After Pancreaticoduodenectomy, Delayed Gastric Emptying, Anastomotic Leaks, Overload FluidView official trial listing → -
Enrolling by invitation NCT NCT06685939
The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)
Zhijun Bao 220 participants Est. completion 2025-07-31 1 siteOther conditions: Pancreatic NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT06710132
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
Not yet reported, Not yet reported EMD Serono Research & Development Institute, Inc. 184 participants Est. completion 2027-12-23 81 sitesOther conditions: Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)View official trial listing → -
Completed NCT NCT06724055
Diagnostic Prediction of Pancreatic Masses
Peking Union Medical College Hospital 110 participants Est. completion 2023-05-31Other conditions: Pancreatic MassesView official trial listing → -
Completed NCT NCT06738914
Twenty Years of Pancreatic Surgery in Iceland
Linkoeping University 244 participants Est. completion 2022-12Other conditions: Pancreatectomy, Pancreatoduodenectomy, Distal Pancreatectomy (DP)View official trial listing → -
Not yet recruiting NCT NCT06756503
Exocrine Pancreatic Insufficiency and Functional Dyspepsia
Maria Marta Piskorz 65 participants Est. completion 2026-08-01Other conditions: Exocrine Pancreatic Insufficiency, DyspepsiaView official trial listing → -
Active, not recruiting NCT NCT06812988
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
Not yet reported Sanofi 84 participants Est. completion 2027-04-29 24 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Not yet recruiting NCT NCT06899269
SPAROBOPAN Project (Spanish Registry of Robotic Pancreatic Surgery)
Hospital General Universitario de Alicante 225 participants Est. completion 2029-06-30Other conditions: Robotic Surgical Procedures, Pancreatic DiseasesView official trial listing → -
Enrolling by invitation NCT NCT06936800
Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP)
Not yet reported Yanqing Li 288 participants Est. completion 2027-12-30 1 siteOther conditions: Chronic Pancreatitis, Pancreatic Duct StonesView official trial listing → -
Completed NCT NCT06949735
Clinical Trial on Digestive Enzymes: Effects on Post-Meal Response to High-Macronutrient Meals
Not yet reported Pancap Pharma Inc. 24 participants Est. completion 2026-02-11 1 siteOther conditions: Gastrointestinal Digestion, Healthy, Gastrointestinal Wellbeing, Gastrointestinal SupplementsView official trial listing → -
Not yet recruiting NCT NCT06954753
Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence
Centre Hospitalier Universitaire de Nice 250 participants Est. completion 2026-12-31Other conditions: Pancreatic Cancer, Pancreatic Cystic LesionsView official trial listing → -
Completed NCT NCT07017712
Sex Differences in Gastrointestinal Cancer Surgery
Medizinische Hochschule Brandenburg Theodor Fontane 870754 participants Est. completion 2023-12-31Other conditions: Sex, Gastrointestinal Cancers, Surgical Resection, Sex DifferencesView official trial listing → -
Completed NCT NCT07022639
Influence of Hospital Volume on Mortality and Length of Hospital Stay After Pancreatic Resection in Switzerland
Cantonal Hospital of St. Gallen 6785 participants Est. completion 2023-03-01 1 siteOther conditions: Pancreatic DiseasesView official trial listing → -
Completed NCT NCT07147374
Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes
Peking Union Medical College Hospital 56 participants Est. completion 2025-07-31 1 siteOther conditions: Pancreatic Cancer, Neoadjuvant Therapy, Robotic SurgeryView official trial listing → -
Not yet recruiting NCT NCT07230301
Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions
Not yet reported Sizhen Wang 20 participants Est. completion 2028-06-30Other conditions: Pancreatic Cancer MetastaticView official trial listing → -
Active, not recruiting NCT NCT07271823
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
Zhejiang Cancer Hospital 100 participants Est. completion 2026-12-31 1 siteOther conditions: Pancreatic Cancer Non-resectableView official trial listing → -
Not yet recruiting NCT NCT07302841
Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer
Not yet reported Tianjin Medical University Cancer Institute and Hospital 28 participants Est. completion 2028-12-30Other conditions: Pancreatic Cancer Non-resectableView official trial listing → -
Active, not recruiting NCT NCT07325435
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
Not yet reported MaryAnn Banerji 60 participants Est. completion 2028-06-30 1 siteType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07621029
Venous Resection in Patients Undergoing Pancreatic Surgery
Sahlgrenska University Hospital 1000 participants Est. completion 2027-12-31 2 sitesOther conditions: IPMN, Pancreatic, Pancreatic Cancer, Resected, Pancreatic Cancer Borderline, Chronic PancreatitisView official trial listing → -
Not yet recruiting NCT NCT07650357
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
Not yet reported Clasp Therapeutics, Inc. 140 participants Est. completion 2029-07 4 sitesOther conditions: Advanced Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Carcinoma, Colorectal CancerView official trial listing → -
Not yet recruiting NCT NCT07709052
Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 180 participants Est. completion 2028-09-01Other conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Intraductal Papillary Mucinous Neoplasm of Pancreas, Pancreatic Intraepithelial NeoplasiaView official trial listing → -
Not yet recruiting NCT NCT07773363
Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer
Not yet reported Tang-Du Hospital 37 participants Est. completion 2028-12-30Other conditions: Pancreatic CancerView official trial listing → -
Not yet recruiting NCT NCT07810309
Metabolic Impact of Pancreatic Duct Decompression
Not yet reported Mayo Clinic 30 participants Est. completion 2030-03Other conditions: Chronic PancreatitisView official trial listing → -
Not yet recruiting NCT NCT07827053
Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer
Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 36 participants Est. completion 2030-09-01Other conditions: Pancreatic Ductal Adenocarcinoma (PDAC)View official trial listing → -
Not yet recruiting NCT NCT07841886
XRAIconnect Image Guidance Software for ERCP Procedures
Not yet reported NYU Langone Health 50 participants Est. completion 2028-01 1 siteOther conditions: Patients Scheduled for Endoscopic Retrograde Cholangiopancreatography (ERCP) ProcedureView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Islet cells, pancreas
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.